News
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
23h
News-Medical.Net on MSNSemaglutide clears liver inflammation and cuts fibrosis in MASH patients, trial showsA phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...
"The results provide strong evidence that semaglutide can help patients by improving liver health and addressing underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results